期刊文献+

乳腺实性乳头状癌临床及病理特征分析

下载PDF
导出
摘要 目的探讨乳腺实性乳头状癌(SPC)临床与病理特点、治疗方法。方法回顾性分析2014年1月至2023年12月确诊的28例乳腺SPC患者(原位型9例、浸润型19例)的临床特征、病理形态及免疫组化染色特征。结果28例SPC患者发病年龄29~82岁(中位年龄79岁),临床表现为乳腺肿块和/或乳头溢液。均手术切除,组织学病理:原位型SPC 9例,浸润型SPC 19例。根据肿瘤细胞巢的边缘完整程度分为原位型和浸润型。瘤细胞形态均匀,呈卵圆形或梭形,细胞核为低-中级别。免疫表型,两种类型的肿瘤细胞ER、PR均呈弥漫性强阳(>90%),大多数HER-2表达阴性(92.8%),CgA阳性率35.7%,Syn阳性率96.4%,CD56阳性率平均28.6%,Ki67为1%~40%。结论乳腺SPC好发于老年女性,两种类型SPC的病理特征、免疫表型均具有较大差异。 Objective To explore the clinical and pathological characteristics and treatment methods of solid papillary carcinoma(SPC)of the breast.Methods Retrospectively analysed the clinical features,pathological morphology,and immunohistochemical staining characteristics of 28 breast SPC patients(9 cases of in situ type and 19 cases of invasive type)diagnosed from January 2014 to December 2023.Results The age of onset of 28 SPC patients ranged from 29 to 82 years(median age 79 years),with clinical manifestations of breast masses and/or nipple discharge.Surgical resection was performed on 9 cases of in situ SPC and 19 cases of invasive SPC.According to the degree of edge integrity of tumor cell nests,they are divided into in situ type and invasive type.The tumor cells had uniform morphology,appearing oval or spindle shaped,and the nuclei are of low to medium grade.Immunophenotypes showed diffuse strong positivity(>90%)for ER and PR in both types of tumor cells,with most HER-2 expression negative(92.8%).The average positivity rates for CgA are 35.7%,Syn are 96.4%,CD56 are 28.6%,and Ki67 ranges from 1%to 40%.Conclusion Breast SPC is more common in elderly women.The pathological characteristics and immunophenotypes of the two types of SPC have significant differences.
出处 《浙江临床医学》 2024年第10期1490-1492,共3页 Zhejiang Clinical Medical Journal
关键词 乳腺癌 实性乳头状癌 免疫表型 临床预后 Breast cancer Solid papillary carcinoma Immune phenotype Clinical prognosis
  • 相关文献

参考文献3

二级参考文献30

  • 1步宏,魏兵.乳腺导管内乳头状肿瘤的病理诊断[J].临床与实验病理学杂志,2006,22(1):1-5. 被引量:19
  • 2Maluf HM,Koemer FC.Solid papillary carcinoma of the breast.A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma.Am J Surg Pathol,1995,19:1237-1244.
  • 3Tavassoli FA,Devilee P,eds.World Health Organization classification of tumors.Pathology and genetics of tumors of the breast and female genital organs.Lyon:IARC Press,2003.
  • 4Lacroix-Triki M,Merry E,Voigt J J,et al.Value of cytokeratin 5/6 immunostaining using D5/16B4 antibody in the spectrum of proliferative intraepithelial lesion of the breast.Acomparative study with CK34βE12 antibody.Virchows Arch,2003,442:548-554.
  • 5Lerwill MF.Current practical applications of diagnostic immunohistochemistry in breast pathology.Am J Surg Pathol,2004,28:1076-1091.
  • 6Azzopardi JG,Muretto P,Goddeeris P,et al.'Carcinoid' tumours of the breast:the morphological spectrum of argyrophil carcinomas.Histopathology,1982,6:549-569.
  • 7Cross AS,Azzopardi JG,Krausz T,et al.A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast.Histopathology,1985,9:21-37.
  • 8Tsang WY,Chan JK.Endocrine ductal carcinoma in situ (E-DCIS) of the breast:a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.Am J Surg Pathol,1996,20:921-943.
  • 9Rosen PP,Oberman HA,eds.Tumors of the mammary gland (Atlas of tumor pathology).3rd Series.Washington DC:American Registry of Pathology,1994.
  • 10Quinn CM,Ostrowski JL.Solid papillary carcinoma of the breast.Am J Surg Pathol,1997,21:256-258.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部